CTNM
Contineum Therapeutics Inc-A
NASDAQ · Pharmaceuticals
$15.00
+0.52 (+3.59%)
Open$14.48
Previous Close$14.48
Day High$15.46
Day Low$14.39
52W High$15.48
52W Low$3.35
Volume—
Avg Volume296.5K
Market Cap547.94M
P/E Ratio—
EPS$-1.31
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+158.8% upside
Current
$15.00
$15.00
Target
$38.82
$38.82
$27.95
$38.82 avg
$46.43
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 273.32M | 248.64M | 220.16M |
| Net Income | 33.71M | 25.85M | 22.01M |
| Profit Margin | 12.3% | 10.4% | 10.0% |
| EBITDA | 45.63M | 48.42M | 37.59M |
| Free Cash Flow | 26.06M | 26.05M | 25.67M |
| Rev Growth | -0.8% | +22.0% | +2.7% |
| Debt/Equity | 0.64 | 0.69 | 0.58 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |